one agent were less likely to persist than those initiated on a prostaglandin analog. Those initiated on parasympathomimetic, beta blocking agent or on more than one agent were less likely to be compliant. Carbonic anhydrase inhibitors users were more likely to be compliant. CONCLUSIONS: Among the new antiglaucoma treatment users, 24% adhered to their treatment. The initial drug influences the likelihood of both persistence and compliance. IC95 [54.7; 66.9]. CONCLUSIONS: This study demonstrated the large part of medical treatment in OAG/OHT. Among them PG are mostly prescribed in monotherapy or fixed association with a high level of satisfaction and compliance according physicians.
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LEVELS OF EMPOWERMENT AMONG PSORIATIC PATIENTS
Pagliarello C, Di Pietro C, Tabolli S IDI IRCCS, Rome, Italy OBJECTIVES: Psoriasis is a chronic skin disorder affecting 1,5-3% of population and its cost to the society has been estimated between $600 and $900/patient/year. Prescription compliance, adherence to an appropriate follow-up program, and changes in patients everyday lives represent an essential approach to reach and maintain clinical remission. Our study wants to measure psoriasis related self-efficacy through a questionnaire specifically developed for this purpose (Psoriasis Empowerment Enquiry in the Routinely practice or PEER). METHODS: The study was an observational, cross-sectional survey. 240 consecutive psoriatic outpatients were asked to fill the questionnaire. The PEER is a 20-item Likert-type questionnaire and generates an overall empowerment score obtained by summing individual items; since we have defined empowerment as mastering the knowledge about psoriasis, learning from past experiences and owning skills to combine both to comply with recommendations of physicians, the PEER was conceived with 3 subscales. RESULTS: A total of 223 respondents were analyzed. Psoriatic patients more than 44 years old reported higher values in the overall score (p 0.01) and in the skills subscale score (p 0.03) while educational level didn't affect it. People suffering from psoriasis from more than one year had a higher overall (p 0.005) and knowledge subscale (p 0.001) scores but no significant score differences were recorded comparing the number of consultations; psoriatic arthritis cases reported higher scores (p 0.001) than those affected by others psoriasis subtype. CONCLUSIONS: patients older than age 44, arthropathic patients or cases affected from more than one year reported higher scores reflecting a higher level of empowerment; psoriatic patients are in great need for self-management of their chronic disease. We introduce a questionnaire to survey empowerment among psoriatic patients that could represent a useful tool to evaluate the efficacy of any kind of interventions in this disabling skin disorder.
PSS32 VALIDATION AND ASSESSMENT OF MEASUREMENT INVARIANCE OF THE EYELASH SATISFACTION QUESTIONNAIRE (ESQ) IN US CANCER PATIENTS
Dang J 1 , Hansen JE 2 , Burgess SM 3 1 Consulting Measurement Group, Torrance, CA, USA, 2 Allergan, Inc., Irvine, CA, USA, 3 Allergan, Inc, Irvine, CA, USA OBJECTIVES: This study was conducted to examine the face and content validity as well as psychometric properties of the Eyelash Satisfaction Questionnaire (ESQ) among cancer patients. Additionally, the aim was to determine whether the measurement properties were equivalent across non-cancer and cancer patients. METHODS: Two focus groups (n 15) were conducted among cancer patients post-chemotherapy to examine the validity of the conceptual framework and test the face and content validity of the ESQ. A web survey was conducted among adults with cancer. Classical Test Theory (CTT) and latent variable modeling techniques were performed using data collected from the web survey. Confirmatory Factor Analysis (CFA), Multiple Group Structural Equation Modeling (MG-SEM), and Differential Item Functioning (DIF) were performed to examine the accuracy and stability of the three domains between non-cancer (n 909) and post-chemotherapy cancer samples (n 595) in the US. RESULTS: Qualitative analysis of the focus group discussions indicated that the conceptual framework established for cancer patients was similar to that for non-cancer patients. Additionally, support was found for the face and content validity of the ESQ. Internal consistency was found to be high across all three domains (Cronbach's 0.93, .90, 0.80) and item-to-domain correlations were high (.55-.84). The factor structure of the original survey fit the cancer data well with factor loadings ranging from .64 to 93. Measurement invariance models provided good fit to the data (NNFI 0.97, RMSEA 0.04). Significant DIF was found between the two samples on two items but the effect sizes of the differences were small (Cohen's d's 0.10) and substantively negligible. CONCLUSIONS: The research findings indicate good overall performance of the ESQ among cancer patients providing support for its use in this population. Additionally, the measurement properties between non-cancer and cancer patients were found to be equivalent. It is important that a questionnaire can detect impact on HRQoL when the disease is 'active' and when is not active in patients with Psoriasis. We have developed a new questionnaire where the items have been created to evaluate the impact of the disease in different phases. METHODS: In order to define the main dimensions, a literature review and a F.G with 5 dermatologists were performed. A semi-structured interview was conducted with 20 patients (10 with active and 10 with non active). From the content of the interviews several items were identified. Each item was subsequently rated by the dermatologist. The items were administered to a sample of 171 patients (52.1% active and 47.9% non active). A factor analysis and a Rasch analysis were performed to obtain the final pilot questionnaire before the validation study. RESULTS: After qualitative reduction, a 37 items questionnaire was obtained (score 0; poor HRQoL to 100; good HRQol) (PSO-LIFE 37). Factor analysis identified 6 dimensions (variance explained of 72.4%). Rasch analysis was used to exclude those items with INFIT or OUTFIT 1.30 and 0.70 or redundant with other items. This final questionnaire (PSO-LIFE 20) has good internal consistency (Cronbach's alpha 0.94). Comparative psychometric performance between PSO-LIFE 37 and PSO-LIFE 20 showed similar internal consistency (0.97 and 0.94), and item correlation-overall score (0.34-0.82 and 0.35-0.81) . PSO-LIFE 20 showed differences (p 0.042) with severity of psoriasis and between patients with active and non active disease (p 0.01) (high score in patients with mild severity, and in patients with non active, which reflect good HRQoL). CONCLUSIONS: PSO-LIFE is a new questionnaire of 20 items, with a priori good psychometric properties though validation is needed through a formal validation process in a sample of adequate size. Preliminary results show that highest impact on HRQoL is observed in patients with active disease.
PSS33 DEVELOPMENT OF A NEW MEASURE FOR ASSESSING HEALTH-RELATED QUALITY OF LIFE IN PATIENTES WITH PSOARIASIS: 'PSO-LIFE'
PSS34 TOOLS TO HELP DIAGNOSIS OF ATOPIC DERMATITIS: A NEED IN PUBLIC HEALTH
Taieb C PFSA, Boulogne, France BACKGROUND: The number of patients with atopic dermatitis is increasing., AD in industrialized countries concerns 5 to 20 % of children between 6&7 years old, of which nearly 10% still suffer from this disease during adulthood. Consequently; atopic dermatitis has become a true public health concern with namely difficulties in diagnosis and patient's management. OBJECTIVES: In order to rapidly and effectively refer patients with AD to dermatologists or paediatricians, our work has aimed at designing and validating a questionnaire of presumed diagnosis of AD METHODS: This questionnaire was designed and based on a large review of international scientific literature, in particular from articles about diagnosis criteria by Hanifi and Rajka and the UK Working Party, interviews of experts and a series of structured interviews of patients with AD of different levels of severity, hence forming a rich and structured verbatim. RESULTS: A questionnaire, using simple vocabulary, and comprising 20 questions, has been designed. Answers to each question are dichotomic; the subject answering either « yes » or « no », so as to prevent any confusion. During test phase, it was found necessary to add « do not know »as a possible answer. 8 questions focus on the medical history of the patient and his/her family (parents and brothers/sisters), 2 questions dealt with difficulties in getting to sleep as well as the quality of sleep, 9
